QORENCE Trademark

Trademark Overview


On Thursday, July 25, 2013, a trademark application was filed for QORENCE with the United States Patent and Trademark Office. The USPTO has given the QORENCE trademark a serial number of 86019567. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 27, 2017. This trademark is owned by Novartis AG. The QORENCE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Diagnostic preparations for medical purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseas...
qorence

General Information


Serial Number86019567
Word MarkQORENCE
Filing DateThursday, July 25, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 27, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2013

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Diagnostic preparations for medical purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, February 27, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 27, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 25, 2016EXTENSION 5 GRANTED
Thursday, July 14, 2016EXTENSION 5 FILED
Thursday, July 14, 2016TEAS EXTENSION RECEIVED
Thursday, January 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 27, 2016EXTENSION 4 GRANTED
Tuesday, January 19, 2016EXTENSION 4 FILED
Tuesday, January 19, 2016TEAS EXTENSION RECEIVED
Friday, July 24, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 23, 2015EXTENSION 3 GRANTED
Friday, July 17, 2015EXTENSION 3 FILED
Friday, July 17, 2015TEAS EXTENSION RECEIVED
Wednesday, March 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 3, 2015EXTENSION 2 GRANTED
Monday, January 19, 2015EXTENSION 2 FILED
Tuesday, March 3, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 19, 2015TEAS EXTENSION RECEIVED
Tuesday, July 22, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, July 20, 2014EXTENSION 1 GRANTED
Sunday, July 20, 2014EXTENSION 1 FILED
Sunday, July 20, 2014TEAS EXTENSION RECEIVED
Tuesday, January 21, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 26, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 18, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 17, 2013ASSIGNED TO EXAMINER
Tuesday, July 30, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 29, 2013NEW APPLICATION ENTERED IN TRAM